Array BioPharma Appoints New CFO
Boulder-based Array BioPharma announced this morning that it has named Patricia Henahan as the company's new Chief Financial Officer. Henahan previously has served at Hospira, AstraZeneca, Eli Lilly and MedImmune, most recently serving as VP of Finance for Hospira's U.S., pharmaceutical-focused business. Array BioPharma is a biopharmaceuticals firm, focused on small molecule drugs for the treatment of cancer. The company is led by Ron Squarer. The company recently inked a big licensing deal with Novartis.
posted on Tuesday, September 8, 2015
Related companies:
Array Biopharma
Related stories:
> Array BioPharma, VentiRx In License Deal
> Array BioPharma Hits Milestone
> Array BioPharma Licenses Rights To Amgen
> Array BioPharma Gets $85M From Novartis
> Array BioPharma Raises $18M From Realty Sale
Techrockies.com Home